ENT Devices | Market Insights | US | 2023
The US ENT device market was severely impacted by the COVID-19 pandemic in 2020, but has already shown significant recovery in 2021 and 2022. Growth over the forecast period will be driven mainly by rising myringotomy tube sales as well as RF and powered instruments, whereas growing clinical evidence will boost adoption of drug-eluting sinus stents. The hand instruments sector will be the slowest growing segment due to the mature nature of the market and lack of innovation.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for ENT devices in the US from 2019 through 2031.
